|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Sutro Biopharma Lands $16,500,000 Series C Funding
|
VentureDeal |
05/08/12 |
San Francisco
|
|
Adimab, ImmunoGen, OvaScience, & More Boston Life Sciences News
|
Erin Kutz |
04/06/12 |
Boston
|
|
Boston Deals: Funding for FRX, Allocure, Good Start, & FirstBest
|
Erin Kutz |
04/03/12 |
Boston
|
|
Good Start Genetics Secures $14,000,000 Series B Financing
|
VentureDeal |
04/02/12 |
Boston
|
|
AlloCure Secures $25,000,000 Series B Funding Round
|
VentureDeal |
04/02/12 |
Boston
|
|
Catabasis Pharmaceuticals Garners $8,000,000 Series A Round
|
VentureDeal |
12/13/11 |
Boston
|
|
AcuFocus Lands $65,000,000 New Funding Round
|
VentureDeal |
11/30/11 |
San Diego
|
|
AlloCure Stem Cell Trial Provides Glimpse of Promising Treatment for Kidney Damage
|
Arlene Weintraub |
11/18/11 |
Boston
|
|
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
11/10/11 |
San Diego
|
|
Rempex Pharmaceuticals Lands $67,500,000 Series B Funding Round
|
VentureDeal |
11/09/11 |
San Diego
|
|
Imagen Biotech, Staffed With Eyetech Vets, Launches in NYC With Plan to Tackle Eye Diseases
|
Arlene Weintraub |
10/25/11 |
New York
|
|
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better
|
Luke Timmerman |
10/24/11 |
National
|
|
Biotech Funding in New York: We Have Some Catching Up to Do
|
Arlene Weintraub |
10/21/11 |
New York
|
|
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment
|
Arlene Weintraub |
10/20/11 |
Boston
|
|
CardioKinetix Obtains $44,000,000 Series E Funding Round
|
VentureDeal |
09/21/11 |
San Francisco
|
|
Entellus Medical Receives $35,000,000 Series E Funding
|
VentureDeal |
08/18/11 |
Detroit
|
|
Cyterix Develops New Twist on an Old Idea, With ‘Smart Bomb’ Cancer Drugs
|
Luke Timmerman |
06/22/11 |
San Francisco
|
|
Cyterix Pharmaceuticals Receives $9,200,000 Series A Funding Round
|
VentureDeal |
06/08/11 |
San Francisco
|
|
Cyterix Raises $9.2M for Cancer Drugs
|
Luke Timmerman |
06/07/11 |
San Francisco
|
|
SV Feels Lonely at the Top, Canaan Finds Biotech Groove, Portola Gets Drug Back, & More in Bay Area Life Sciences News
|
Luke Timmerman |
03/25/11 |
San Francisco
|
|
SV Life Sciences, Flush with $523M Fund, On the Hazard of Having a Lot of Dough
|
Luke Timmerman |
03/23/11 |
National
|
|
CardioFocus Finds $30.6M for Atrial Fibrillation Treatment
|
Ryan McBride |
02/25/11 |
Boston
|
|
Biotech Vet Gerngross Dishes Out More Details On Latest VC-Backed Startup Arsanis
|
Ryan McBride |
02/15/11 |
Boston
|
|
Stromedix Adds Debt to Finance Clinical Trial, Eliza and Google Team Up for Health IT Website, Arsanis Gets $10M, & More Boston-Area Life Sciences News
|
Erin Kutz |
02/11/11 |
Boston
|
|
NaviSite Bought By Time Warner, BG Medicine Goes Public, Omnicom Gets Communispace, & More Boston-Area Deals News
|
Erin Kutz |
02/09/11 |
Boston
|
|
Secretive Biotech Arsanis Raises $9.6M
|
Ryan McBride |
02/08/11 |
Boston
|
|
Bliss Healthcare, Founded by MIT Sloan Grad, Starts New Web-Savvy Home Care Service
|
Ryan McBride |
02/04/11 |
Boston
|
|
Genocea Announces New CEO, Pfizer to Add Jobs In MA, Ocular Raises $14M, and More Boston-Area Life Sciences News
|
Erin Kutz |
02/04/11 |
Boston
|
|
Ocular Therapeutix Garners $14,000,000 Series D Round
|
VentureDeal |
02/02/11 |
Boston
|
|
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners
|
Ryan McBride |
12/15/10 |
Boston
|
|
Page 1 of
4 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.